Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2026-03-05 @ 6:40 PM
Study NCT ID:
NCT01794767
Status:
SUSPENDED
Last Update Posted:
2015-10-29
First Post:
2013-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
Sponsor:
University of Florence
Organization:
Study Overview
Official Title:
Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
Status:
SUSPENDED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
difficult recruiting
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to verify if the periodic flush with normal saline 0.9% NaCl causes a longer or equal duration of patency of peripheral venous catheters, compared with heparin solution 50 U / ml flush, in children from 2 years to 14 years. Only 22 and 24 gauge catheters Will be included in the study.The study will assess in particular:
* the difference of permanence in situ of the device
* the difference in incidence of complications (in detail: obstruction, phlebitis, thrombocytopenia, systemic anticoagulation)
* the difference in costs between use of saline normal saline 0.9% NaCl solution and heparinized 50 U / ml.
* the difference of permanence in situ of the device
* the difference in incidence of complications (in detail: obstruction, phlebitis, thrombocytopenia, systemic anticoagulation)
* the difference in costs between use of saline normal saline 0.9% NaCl solution and heparinized 50 U / ml.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: